News

Botower Capital invest in Melasma Pharmaceuticals

19 July 2018

Botower Capital invest in Melasma Pharmaceuticals with support for incubation space, legal, technology and Business development services.

About Botower Capital - Your partner for life science inventions

Micar Innovation create spin out company Melasma Pharmaceuticals by grants an exclusive option to license and develop MIC8411

19 July 2018

Micar Innovation (Sofia, Bulgaria) today announced signing of a definitive agreement in which Micar Innovation create new spin out company Melasma Pharmaceuticals. Under terms of the agreement, Micar Innovation grants Melasma Pharmaceuticals (Sofia - Bulgaria) an exclusive option to license and develop MIC8411 drugs targeting Melasma disease. Melasma Pharmaceuticals capital is in the hands of Micar Innovation driven by impact and provide value to our future investors.

Spin off: Micar Innovation list the subsidiary on the public market as an independent public company Melasma Pharmaceuticals, so that investors who are only interested in the Melasma business can invest only in this section. The independent new company usually operates with more accountability and responsibility.

About Micar Innovation - Your Drug Discovery Factory